Hugel resubmits application to FDA for botulinum toxin product

South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...

Hugel names ex-CEO of LG Household & Health Care as chairman

South Korea's biopharmaceutical company Hugel Inc. on Friday said it appointed Cha Suk-yong, former CEO and vice chairman of LG Household & Heal...

US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle

Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...

Hugel accelerates European botox sales with Poland's approval

Hugel Inc., South Korea’s largest maker of botulinum toxin products used to treat overactive muscles and facial wrinkles, has won sales approv...

Medytox-Hugel dispute over botox strain intensifies with ITC probe

A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...

Medytox files complaint with ITC against Hugel over botox strain

South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...

GS ups spending to take control of botox maker Hugel

South Korea’s energy-to-retail conglomerate GS Group has increased its spending to become the largest shareholder in Hugel Inc., the country's...

Behind the scenes of GS-led group's $1.5 bn Hugel purchase

South Korea's energy-to-construction conglomerate GS Group was not considered a serious bidder when it entered the race for a 46.9% stake in the cou...

Bain Capital sells management rights of Hugel to GS-led group for $1.5 bn

A consortium led by South Korea’s energy-to-construction conglomerate GS Group has acquired the country’s top botox maker Hugel Inc. fro...

Mubadala joins GS-led group to buy Korean botox maker

Abu Dhabi’s sovereign investor Mubadala Investment Co. joined a consortium led by South Korean GS Group to acquire the country’s top bot...

Bid for botox maker Hugel to kick off in late July, attracts PEFs

The bid to acquire a controlling stake in Hugel Inc., South Korea’s leading maker of botulinum toxin, more commonly known as botox, from US pr...

Samsung looks to acquire bio company, reviews botox maker Hugel

Samsung Group is looking to buy a biopharmaceutical company as the top South Korean business conglomerate is resuming merger and acquisition activit...

GS Group joins race to acquire Korea’s botox maker Hugel

A consortium led by South Korea’s GS Group is in talks to acquire a controlling stake in Hugel Inc., the country’s top maker of botulinu...